News & Events

Updates from the team regenerating cartilage.

Funding, research milestones, and company news as Stemora advances the first regenerative therapy targeting osteoarthritis at its root cause.

Stemora receives Maryland Industrial Partnerships (MIPS) award to engineer controlled-release formulations for STM-01

A $100,000 matching grant from the MIPS program will fund a collaboration with the University of Maryland to develop hydrogel formulations that control the timed release of STM-01's regenerative cues.

Read the announcement

TEDCO's Pre-Seed Rural Business Innovation Initiative invests in Stemora

TEDCO has invested $25,000 in Stemora through its Pre-Seed Rural Business Innovation Initiative (RBII) Fund, backing the Frederick-based company's regenerative approach to osteoarthritis.

Read the announcement

FundingJune 25, 2026

Stemora receives NSF SBIR Phase I award to advance breakthrough cartilage regeneration technology

A $305,000 National Science Foundation grant will accelerate development of Stemora's one-step, intraoperative regenerative therapy for cartilage injuries and osteoarthritis.

Read the announcement

FundingJanuary 15, 2026

Stemora named Maryland Stem Cell Research Fund Commercialization Awardee

Stemora joins the R1-2026 awardees of the Maryland Stem Cell Research Fund's Commercialization grant program, advancing skeletal stem cell therapies for cartilage regeneration.

Read the announcement